L372-0817 Screening compound: N-[(4-methylphenyl)methyl]-2,5-dioxo-1-[4-(trifluoromethyl)phenyl]-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide

L372-0817 Screening compound: N-[(4-methylphenyl)methyl]-2,5-dioxo-1-[4-(trifluoromethyl)phenyl]-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide
L372-0817 Screening compound: N-[(4-methylphenyl)methyl]-2,5-dioxo-1-[4-(trifluoromethyl)phenyl]-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L372-0817
N-[(4-methylphenyl)methyl]-2,5-dioxo-1-[4-(trifluoromethyl)phenyl]-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L372-0817

Molecular Formula

C25H21F3N2O3 (C25 H21 F3 N2 O3)

Compound Name

N-[(4-methylphenyl)methyl]-2,5-dioxo-1-[4-(trifluoromethyl)phenyl]-1,2,5,6,7,8-hexahydroquinoline-3-carboxamide

IUPAC name

N-[(4-methylphenyl)methyl]-25-dioxo-1-[4-(trifluoromethyl)phenyl]-125678-hexahydroquinoline-3-carboxamide

SMILES

Cc1ccc(CNC(C2=CC(C(CCC3)=O)=C3N(c3ccc(C(F)(F)F)cc3)C2=O)=O)cc1

InChI

InChI=1S/C25H21F3N2O3/c1-15-5-7-16(8-6-15)14-29-23(32)20-13-19-21(3-2-4-22(19)31)30(24(20)33)18-11-9-17(10-12-18)25(26,27)28/h5-13H,2-4,14H2,1H3,(H,29,32)

InChI Key

YXOKMHARNCKAPT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15125684

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

454.45

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.754

Distribution Coefficient, logD

3.752

Water Solubility, LogSw

-4.17

Polar Surface Area

52.993

Acid Dissociation Constant (pKa)

9.76

Base Dissociation Constant (pKb)

-5.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

L372-0817 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L372-0817 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L372-0817?
Check Price and Availability of L372-0817, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L372-0817 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L372-0817
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L372-0817
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L372-0817 available by request